首页> 外文期刊>Acta Neurochirurgica >Results of endovascular treatment of middle cerebral artery aneurysms after first giving consideration to clipping
【24h】

Results of endovascular treatment of middle cerebral artery aneurysms after first giving consideration to clipping

机译:首次考虑夹闭术后脑中动脉瘤的腔内治疗结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Middle cerebral artery (MCA) aneurysms are among the more challenging aneurysms for endovascular treatment. We report a contemporary 5-year experience with endovascular therapy for MCA aneurysms at a high-volume neurovascular center. Methods: Review of prospectively maintained intracranial aneurysm database. Results: Between 2005 and 2009, 148 patients underwent treatment of 149 MCA aneurysms at our hospital, of which 33 patients with 34 aneurysms underwent endovascular therapy. Among these 33 patients, 14 presented with subarachnoid hemorrhage. Eleven patients were treated with stent-assisted coiling, 1 with balloon-assisted coiling, and the remainder with coiling alone. Three patients required repeat endovascular treatment. There were 7 periprocedural complications, including intraprocedural aneurysm rupture resulting in death in 2 patients. Two patients died at later dates from remote aneurysm rehemorrhage. Average follow-up of remaining patients was 17.1 months radiographically, and 20.3 months clinically. Average modified Rankin scale (mRS) score at last follow up was 2.09, with 17 patients with mRS 0/1 and 5 patients with mRS 2. Fifteen patients showed evidence of radiographic residual at last follow up: 13 were simple neck residuals. Unruptured status and saccular aneurysms were associated with mRS 0/1 outcome (each p < 0.05). Conclusions: At our hospital, MCA aneurysms are being treated with endovascular techniques, but in a minority of patients. Despite the rate of residual neck remnants, few retreatments were necessary and few rehemorrhages occurred. The periprocedural complication rate was not insignificant; therefore, in more recent years and at present, most MCA aneurysms are considered for clipping first at our center.
机译:背景:大脑中动脉(MCA)动脉瘤是血管内治疗中更具挑战性的动脉瘤之一。我们报告了在大容量神经血管中心进行MCA动脉瘤血管内治疗的5年当代经验。方法:审查前瞻性维持的颅内动脉瘤数据库。结果:2005年至2009年,我院共148例患者接受了149例MCA动脉瘤的治疗,其中33例34动脉瘤的患者接受了血管内治疗。在这33例患者中,有14例出现蛛网膜下腔出血。 11例患者接受了支架辅助卷绕治疗,1例接受了球囊辅助卷绕治疗,其余患者仅接受了卷绕治疗。三名患者需要重复血管内治疗。共有7例围手术期并发症,包括术中动脉瘤破裂导致2例死亡。稍后有2例患者因远端动脉瘤再出血死亡。其余患者的平均影像学随访时间为17.1个月,临床平均随访时间为20.3个月。最后一次随访的平均改良兰金评分(mRS)评分为2.09,其中17例mRS 0/1的患者和5例mRS 2的患者。15例患者的影像学证据显示最后一次随访:13例为单纯颈部残留。正常状态和囊状动脉瘤与mRS 0/1结果相关(每个p <0.05)。结论:在我们医院,MCA动脉瘤正在采用血管内技术治疗,但少数患者接受了治疗。尽管残留的颈部残余物的比率很高,但几乎没有必要进行再治疗,也很少发生再出血。围手术期并发症发生率不显着。因此,在最近几年和目前,大多数MCA动脉瘤被认为首先在我们中心进行切除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号